Purpose of the Procedure
- Identify the primary organ where the cancer originated.
- Enable oncologists to select the most effective targeted therapy.
- Avoid unnecessary or ineffective systemic treatments.
Book Molecular Profiling for CUP | Lahalak Medical Platform
Advanced genetic profiling technology designed to identify the primary tissue of origin in metastatic cancers of unknown primary, enabling oncologists to implement precise, targeted treatment strategies for better patient outcomes.
Scientific name: Molecular Profiling for Cancer of Unknown Primary (CUP)
A specialized laboratory test analyzing gene expression or molecular markers to pinpoint the primary site of metastatic cancer, facilitating the selection of optimal targeted or systemic therapies for patients.
Service type
Advanced laboratory test
Duration
7-14 business days
Fasting
Fasting is not required
Included Services
- Gene expression profiling
- Immunohistochemistry (IHC) markers
- Detailed clinical diagnostic report
Medical Service Information
Who Should Get This Test?
- Patients with metastatic cancer where the primary site is unknown.
- Cases requiring precise molecular subtype identification.
- Patients seeking a second opinion to confirm the cancer's origin.
Understanding the Results
- The genetic signature of the tumor is compared against a database of known cancers.
- The report indicates the most likely tissue of origin.
- Results must be reviewed by a specialized medical oncologist.
Conditions & Notices
- Adequate tissue biopsy sample must be available
- Previous pathology and clinical reports are required
Medical services you might also like
